Interpretation of key updates in 2024 CSCO guidelines for advanced breast cancer
10.12354/j.issn.1000-8179.2024.20240987
- VernacularTitle:2024 CSCO指南晚期乳腺癌更新要点解读
- Author:
Liu ZHEN
1
;
Yuan YANG
1
;
Jiang ZEFEI
1
Author Information
1. 中国人民解放军总医院第五医学中心肿瘤医学部(北京市 100071)
- Publication Type:Journal Article
- Keywords:
advanced breast cancer;
diagnosis and treatment guidelines;
key points of update;
Chinese Society of Clinical Oncology(CSCO)
- From:
Chinese Journal of Clinical Oncology
2024;51(23):1223-1226
- CountryChina
- Language:Chinese
-
Abstract:
The 2024 CSCO Breast Cancer Diagnosis and Treatment Guidelines have synthesized key international and domestic research ad-vancements in 2023,considering drug accessibility and medical insurance and incorporating a measure of Chinese experts consensus to up-date diagnosis and treatment recommendations.These guidelines recommend best practices for treatment of different types of breast can-cer,including hormone receptor-positive(HR+),HER2-positive and triple-negative breast cancer.Moreover,the guidelines include diagnosis and treatment recommendations for HER2-low advanced breast cancer and provision of standardized and precise treatment options to pa-tients with different cancer types and stratification.This study aimed to interpret the key updated points for advanced breast cancer treat-ment.
